| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | 144/A |
| 16 Nov 2026 | 144 |
| 13 Nov 2026 |
Form 4: Burke William W, Director
Received 18,000 shares by exercise or conversion ($84.6K) · Sold 18,000 shares ($479K) |
| 12 Nov 2026 | 144 |
| 10 Nov 2026 |
Form 4: Taylor Joseph Michael, Director
Sold 10,200 shares ($278K) |
| 09 Nov 2026 | 144 |
| 04 Nov 2026 |
Form 4: Woo Raymond, Chief Technology Officer
Received 4,887 shares by exercise or conversion ($17.9K) · Sold 4,887 shares ($132K) |
| 03 Nov 2026 | 10-Q |
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition
Sunnyvale, Calif. – November 3, 2026 – CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financi... |
| 02 Nov 2026 | 144 |
| 02 Oct 2026 |
Form 4: Woo Raymond, Chief Technology Officer
Received 4,887 shares by exercise or conversion ($17.9K) · Sold 4,887 shares ($119K) |
| 01 Oct 2026 | 144 |
| 17 Sep 2026 |
Form 4: Chao Xingjuan, Director
Sold 20,846 shares ($522K) |
| 17 Sep 2026 |
Form 4: Blumberg Scott, Chief Financial Officer
Received 846 shares by exercise or conversion ($7.96K) · Sold 846 shares ($21.2K) |
| 15 Sep 2026 | 144 |
| 15 Sep 2026 | 144 |
| 10 Sep 2026 |
Form 4: Foehr David, Senior VP, Finance and PAO
Sold 9,255 shares ($224K) · Received 7,500 shares by exercise or conversion ($35.3K) |
| 10 Sep 2026 |
Form 4: Woo Raymond, Chief Technology Officer
Received 13,276 shares by exercise or conversion ($36.7K) · Sold 4,887 shares ($119K) |
| 08 Sep 2026 | 144 |
Loading...